Prevention of Steroid-Induced Neuropsychiatric Complications With Neuroleptic Drugs: A Review

Am J Hosp Palliat Care. 2022 Apr;39(4):472-476. doi: 10.1177/10499091211034771. Epub 2021 Aug 13.

Abstract

Corticosteroids are used for a multitude of indications in palliative patients. In this narrative review, we aim to review literature on the treatment and prevention of neuropsychiatric complications of steroids. For prevention, only lamotrigine had a positive effect in a small number of studies. For treatment, olanzapine appears to be nearly universally effective at low doses, but randomized trial evidence is lacking. Further randomized clinical trials are necessary to elucidate data-driven guidelines for prevention and treatment of corticosteroid-induced neuropsychiatric symptoms. Until further data are available, it is reasonable to consider low dose olanzapine for any patient taking 40 mg of prednisone or its equivalent, especially those with a history of depression or neuropsychiatric symptoms.

Keywords: complications; corticosteroids; neuroleptics; neuropsychiatric; olanzapine; palliative care; prevention; treatment.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Antipsychotic Agents* / adverse effects
  • Humans
  • Olanzapine / therapeutic use
  • Prednisone / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Antipsychotic Agents
  • Olanzapine
  • Prednisone